等待开盘 04-02 09:30:00 美东时间
-0.910
-2.06%
今日重点评级关注:Evercore ISI集团:维持Caribou Biosciences"跑赢大市"评级,目标价从11美元升至13美元;富国银行:上调uniQure评级至"超配",目标价从15美元升至60美元
03-10 15:05
Ratings for Root (NASDAQ:ROOT) were provided by 4 analysts in the past three mo...
03-10 06:01
UBS analyst Brian Meredith maintains Root (NASDAQ:ROOT) with a Neutral and lowers the price target from $90 to $52.
03-10 04:38
Oversold stocks in financial sector present buying opportunity. RSI indicator compares strength of stock on up & down days, below 30 is oversold.
03-04 19:05
BRIEF-Roots Corporation Announces Strategic Review March 3 (Reuters) - Roots Corp ROOT.TO : ROOTS CORPORATION ANNOUNCES STRATEGIC REVIEW ROOTS CORP - REVIEW INCLUDES POTENTIAL SALE OF ROOTS CORPORATION Source text: ID:nBw2BH29Ga Further company coverage: ROOT.TO (( Reuters.Briefs@thomsonreuters.com
03-03 20:30
U.S. RESEARCH ROUNDUP-Cars.Com, Dell, Zscaler Feb 27 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Cars.Com, Dell Technologies and Zscaler, on Friday. HIGHLIGHTS * Cars.Com Inc CARS.N : JP Morgan cuts to neutral from o
02-27 16:20
今日重点评级关注:HC Wainwright & Co.:维持NovoCure"买入"评级,目标价从47美元升至49美元;Citizens:维持Ironwood医药"跑赢大市"评级,目标价从8美元升至10美元
02-27 11:07
Keefe, Bruyette & Woods analyst Thomas McJoynt-Griffith maintains Root (NASDAQ:ROOT) with a Outperform and lowers the price target from $150 to $104.
02-26 20:11
U.S. RESEARCH ROUNDUP-Arcellx, Costar Group, Magnite Feb 26 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Arcellx, Costar Group and Magnite, on Thursday. HIGHLIGHTS * Arcellx Inc ACLX.O : Guggenheim cuts to neutral fro
02-26 15:31
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 基于Root业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **2025年全年表现:** - 营收增长29%,管理层称公司处于"历史最强位置" - 净利润达到4000万美元,同比增长30%(增加900万美元) - 总承保保费(Gross Written Premium)同比增长1619%,显示保费规模大幅扩张 - 调整后EBITDA为1.32亿美元,较2024年的1.12亿美元增长 - 营业收入为6200万美元,较上年的7900万美元下降 - 年末拥有3.12亿美元无担保资本 **2025年第四季度表现:** - 总承保保费和总赚取保费同
02-26 12:18